2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Monday, May 4, 2015

5:30pm-6:30pm: The Utility of Non-Invasive Intra Abdominal Pressure Monitoring After Pediatric Abdominal Organ Transplantation

E. Harkin,¹ M. McLeod,¹ K. Khan,² A. Natarajan.³

Poster Session C: Late Breaking • Exhibit Hall E

5:30pm-6:30pm: Tissue Engineering Human Kidneys for Costimulation Blockade

L. Brasile,¹ N. Henry,¹ A. Meyer,¹ B. Stubenitsky.²

Poster Session C: Antigen Presenting Cells in Alloimmune Responses/B Cells and Antibody in Alloimmune Responses • Exhibit Hall E

5:30pm-6:30pm: Toxicity Driven Conversion to Belatacept in Kidney Transplant Recipients

E. Cohen, W. Asch, R. Formica, E. Tichy.

Poster Session C: Immunosuppression/Compliance • Exhibit Hall E

5:30pm-6:30pm: Transplant Glomerulopathy in a Novel Model of Chronic Antibody Mediated Rejection Is Associated With DSA and Glomerular IgM

S. Panzer,¹ S. Reese,¹ N. Wilson Schlei,¹ W. Zhong,² A. Djamali.¹

Poster Session C: Antigen Presenting Cells in Alloimmune Responses/B Cells and Antibody in Alloimmune Responses • Exhibit Hall E

5:30pm-6:30pm: Type of Caregiver and Outcome After Mechanical Circulatory Support Placement

H. Henry, F. Arabia, M. Kittleson, L. Czer, E. Passano, J. Yabuno, S. Siddiqui, E. Antifantis, D. Chang, J. Kobashigawa.

Poster Session C: "Loss of Breath": VADs and Other Pre-Heart Transplant Matters • Exhibit Hall E

5:30pm-6:30pm: U.S. National Experience of Liver Transplantation Using Allografts from Octogenarian Donors

C. Bhati, I. Tzvetanov, R. Garcia-Roca, J. Oberholzer, E. Benedetti, H. Jeon.

Poster Session C: Liver Donation and Allocation • Exhibit Hall E

5:30pm-6:30pm: Unknown Urological Pathologies in Renal Allografts from Deceased Donors. Should Image Evaluation Be Routinely Performed?

K. Yamaçake, W. Nahas, I. Antonopoulos, H. Kanashiro, R. Kato, A. Bull, R. Falci, A. Piovesan.

Poster Session C: ECD/DCD/high KDPI • Exhibit Hall E

5:30pm-6:30pm: Use of MELD Exception Points in Patients With Hepatic Neuroendocrine Tumor Metastases: Variable Use and Proposed Criterion for Approval

Y. Nobel,¹ D. Goldberg.^2,3,4

Poster Session C: Liver Donation and Allocation • Exhibit Hall E

5:30pm-6:30pm: Utility and Outcomes of Expanded Screening Among Live Solid Organ Donors

A. Rosen, B. Ho, M. Ison.

Poster Session C: Living Donor Issues 2 • Exhibit Hall E

5:30pm-6:30pm: Utilization and Characteristics of Kidney Donors in the US by OPTN-Defined Increased Risk Donor Status

M. Ison,^1,2 B. Ho,² J. Leventhal,² D. Ladner.²

Poster Session C: ECD/DCD/high KDPI • Exhibit Hall E